Magnora ASA
OTC:SVMRF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Magnora ASA
OTC:SVMRF
|
NO |
|
Altimmune Inc
NASDAQ:ALT
|
US |
|
Parkway Corporate Ltd
ASX:PWN
|
AU |
|
B
|
Brait plc
JSE:BAT
|
MU |
|
China Construction Bank Corp
SSE:601939
|
CN |
|
T
|
TIME dotCom Bhd
KLSE:TIMECOM
|
MY |
|
E
|
Eurosnack SA
WSE:ECK
|
PL |
|
Tekmar Group PLC
LSE:TGP
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SVMRF's stock price target?
Price Target
3.68
USD
According to Wall Street analysts, the average 1-year price target for SVMRF is 3.68 USD with a low forecast of 3.02 USD and a high forecast of 4.11 USD.
What is the Revenue forecast for Magnora ASA?
Projected CAGR
39%
Over the last 13 years, the compound annual growth rate for Revenue has been -13%. The projected CAGR for the next 3 years is 39%.
What is the Pre-Tax Income forecast for Magnora ASA?
Projected CAGR
118%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 118%.
What is the Net Income forecast for Magnora ASA?
Projected CAGR
85%
The compound annual growth rate for Net Income over the next 3 years is 85%.